InvestorsHub Logo
Followers 105
Posts 4897
Boards Moderated 0
Alias Born 10/06/2011

Re: WeeZuhl post# 365482

Friday, 02/11/2022 12:22:48 AM

Friday, February 11, 2022 12:22:48 AM

Post# of 402167
A worthy question. But not worded in a way that a CEO of a business, even a little business like Elite, could answer.

Now why is that?

Imagine for a moment Elite is working on an ANDA different in the ways that are inferred. Why would a CEO reveal answers that are likely the basis for product development? The answer can be found in another question - Why reveal the answers to questions others might be seeking? The very basis for competitive advantage is doing that which others cannot. It is quintessential VRIN when others cannot do what you can and business malpractice to give the competition the answers or even suggesting leads they are likely spending money to discover. Remember, time to market matters. As does early entry. Knowledge is a costly weapon and is not to be shared.

I trust that Elite will save their evidence for the FDA not the admiring public, and certainly not listeners to a CC who may or may not be investors and may or may not be seeking business intelligence...and that is not oxymoronic.

Once again, medical knowledge is one thing and investing in business another. But assuredly, both are very far from the knowledge needed to actually run a business effectively. For all the noise, it remains that Elite is profitable. In fact,

40 percent of small businesses are profitable, 30 percent break even and 30 percent are continually losing money. Here is the link... https://www.chamberofcommerce.org/small-business-statistics/

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News